The presence of thrombocytopenia in NDMM patients significantly correlated with invasive clinical manifestations, including high myeloma burden, severe anemia, low albumin levels, renal failure, and elevated β2‐MG and LDH levels. This evidence concerns the gene ALB and anemia (phenotype).